PSMA PET

Jianliang Liu1,2,3, Thomas P Cundy4, Dixon T S Woon1,3

  • 1E.J. Whitten Prostate Cancer Research Centre, Epworth Healthcare, Melbourne, VIC 3005, Australia.

Cancers
|February 10, 2024
PubMed
概括

人工智能 (AI) 在改善前列腺特异性膜抗原 (PSMA) 和转移性前列腺癌 (mPCa) PET扫描方面表现有前途. 人工智能提高了报告的准确性和效率,解决了当前的诊断变化.